Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase NA 1Phase 1/2 1

Status

Completed 5Unknown 2Terminated 2Withdrawn 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Radiation Injuries 1Pain 1Mucositis 1Head and Neck Neoplasms 1Esophagitis 1

Interventions

Cisplatin 62Carboplatin 52Paclitaxel 49Radiotherapy 47Docetaxel 42Gemcitabine 38Cyclophosphamide 36Rituximab 33Capecitabine 28Fluorouracil 27Dexamethasone 27Doxorubicin 26Prednisone 21Bevacizumab 20Pemetrexed 19Oxaliplatin 18Leucovorin 18pembrolizumab 17Vincristine 17Etoposide 17Cytarabine 15Imatinib Mesylate 14Drug Therapy 14Irinotecan 13Filgrastim 13Zoledronic Acid 12Trastuzumab 12Radiosurgery 12Erlotinib Hydrochloride 12Goserelin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Terminated × Glutamine × Clear all
NCT01952847 2022-06-15

Randomized Trial of Glutamine in Patients With Mucositis or Esophagitis

M.D. Anderson Cancer Center

Phase 3 Terminated
77 enrolled 28 charts
Other

Esophagitis, Mucositis

NCT00006994 2015-11-18

S9908: Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat

SWOG Cancer Research Network

Phase 3 Terminated
23 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Pain, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡